Skip to Content

What is the status of alogliptin's cv trial?

Responses (1)

suzanne66 16 Mar 2010

August 28 - Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes. - scroll down to 14 - they are still recruiting patients. free discount card

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions